| An RNA alternative to human transferrin: a new tool for targeting human cells SE Wilner, B Wengerter, K Maier, MLB Magalhães, DS Del Amo, S Pai, ... Molecular Therapy-Nucleic Acids 1, 2012 | 151 | 2012 |
| From selection hits to clinical leads: progress in aptamer discovery KE Maier, M Levy Molecular Therapy Methods & Clinical Development 3, 2016 | 116 | 2016 |
| The role of microsporidian polar tube protein 4 (PTP4) in host cell infection B Han, V Polonais, T Sugi, R Yakubu, PM Takvorian, A Cali, K Maier, ... PLoS pathogens 13 (4), e1006341, 2017 | 95 | 2017 |
| Delivery of siRNAs to dendritic cells using DEC205-targeted lipid nanoparticles to inhibit immune responses JA Katakowski, G Mukherjee, SE Wilner, KE Maier, MT Harrison, ... Molecular Therapy 24 (1), 146-155, 2016 | 85 | 2016 |
| Growth inhibition of Staphylococcus aureus by mixed monolayer gold nanoparticles J Bresee, KE Maier, AE Boncella, C Melander, DL Feldheim Small 7 (14), 2027-2031, 2011 | 68 | 2011 |
| A comparative analysis of cell surface targeting aptamers L Kelly, KE Maier, A Yan, M Levy Nature Communications 12 (1), 6275, 2021 | 62 | 2021 |
| A new transferrin receptor aptamer inhibits new world hemorrhagic fever mammarenavirus entry KE Maier, RK Jangra, KR Shieh, DK Cureton, H Xiao, EL Snapp, ... Molecular Therapy-Nucleic Acids 5, 2016 | 49 | 2016 |
| A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response P Nacharaju, C Tuckman-Vernon, KE Maier, J Chouake, A Friedman, ... Nitric Oxide 27 (3), 150-160, 2012 | 45 | 2012 |
| Identification of antibiotics using small molecule variable ligand display on gold nanoparticles J Bresee, KE Maier, C Melander, DL Feldheim Chemical Communications 46 (40), 7516-7518, 2010 | 44 | 2010 |
| Covalently tethering siRNA to hydrogels for localized, controlled release and gene silencing MK Nguyen, CT Huynh, A Gilewski, SE Wilner, KE Maier, N Kwon, M Levy, ... Science advances 5 (8), eaax0801, 2019 | 35 | 2019 |
| AptCompare: optimized de novo motif discovery of RNA aptamers via HTS-SELEX AG Kevin R Shieh, Christina Kratschmer, Keith E Maier, John M Greally ... Bioinformatics, 2020 | 17 | 2020 |
| Improved Synthesis and In Vitro Evaluation of an Aptamer Ribosomal Toxin Conjugate L Kelly, C Kratschmer, KE Maier, AC Yan, M Levy nucleic acid therapeutics 26 (3), 156-165, 2016 | 17 | 2016 |
| To PEGylate or not to PEGylate therapeutics? KE Maier, CP Rusconi, M Levy Cell Chemical Biology 26 (5), 615-616, 2019 | 8 | 2019 |
| Transferrin receptor aptamers and aptamer-targeted delivery M Levy, KE MAIER, SE WILNER | 1 | 2013 |
| Erratum: An RNA alternative to human transferrin: A new tool for targeting human cells (Molecular Therapy-Nucleic Acids (2013) 2 e79 SE Wilner, B Wengerter, K Maier, MDLB Magalhães, DS Del Amo, S Pai, ... Molecular Therapy-Nucleic Acids 2, e79, 2013 | 1 | 2013 |
| Direct multi-omics for the masses: Linking DNA methylation to chromatin targets via TEM-seq KE Maier, VU Sunitha Kumary, BJ Venters, A Hickman, A Vaidya, ... Cancer Research 84 (6_Supplement), 7027-7027, 2024 | | 2024 |
| Abstract P17: Epigenomic fingerprinting of limited primary immune cells using automated CUT&RUN EN Weinzapfel, KE Maier, MR Marunde, VUS Kumary, CPL Windham, ... Blood Cancer Discovery 5 (2_Supplement), P17-P17, 2024 | | 2024 |
| Ubiquitinated histone H2B as gatekeeper of the nucleosome acidic patch CW Hicks, S Rahman, SL Gloor, JK Fields, NL Husby, A Vaidya, KE Maier, ... bioRxiv, 2024.02. 22.581437, 2024 | | 2024 |
| Automated Cut&run Brings Scalable Epigenomic Profiling to Hematology KE Maier, MR Marunde, VUS Kumary, CP Lin, DN Maryanski, ... Blood 142, 7150, 2023 | | 2023 |
| Stem-loop compositions and methods for inhibiting vascular endothelial growtn factor C Erickson, CP Rusconi, M Levy, KE Maier, SE Thacker, D Parks US Patent App. 17/422,034, 2022 | | 2022 |
Samantha E. WilnerUrsinus College在 ursinus.edu 的电子邮件经过验证
Samantha E. WilnerUrsinus College在 ursinus.edu 的电子邮件经过验证